Victor Pineda
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Victor Pineda has a total of 63 co-authors. Here are the top co-authors by number of shared publications:
- Adria Roset-Altadill
Department of Radiology, Hospital Universitari de Girona Doctor Josep Trueta, Institut d’Investigació Biomèdica de Girona (IDIBGI), Spain (A.R.-A.).
1 shared publication - Albert Roque
Department of Radiology, Hospital Universitari Vall d'Hebron, Barcelona, Spain; Nuclear Cardiology and Hybrid Cardiovascular Imaging Unit, Department of Nuclear Medicine, Hospital Universitari Vall d'Hebron, Barcelona, Spain; Universitat Autònoma de Barcelona, Barcelona, Spain
1 shared publication - Alberto Martín Hidalgo
From the Department of Radiology, Hospital Universitari de Girona Doctor Josep Trueta, Av França S/N, 17007, Girona, Spain (A.R.A., N.C., S.J., A.H., V.P.); Department of Radiology, Hospital Clinic de Barcelona, Barcelona, Spain (B.D.X.); Department of Cardiology, Clinica Colon, Buenos Aires, Argentina (L.R.E.); and Division of Cardiothoracic Imaging, Department of Radiology, University of Colorado Anschutz Medical Campus, Aurora, Colo (D.V.).
1 shared publication - Alejandro González
Neurovascular Research Program, Seville Biomedical Research Institute, Seville, Spain.
1 shared publication - Alfredo Guillén-Del-Castillo
Unit of Autoimmune Diseases, Department of Internal Medicine, Hospital Universitario Vall d’Hebron, Barcelona, Spain
1 shared publication - Ana García-Álvarez
CIBER Cardiovascular, Instituto de Salud Carlos III, Madrid, Spain (N.R.-L., N.M.-A., C.G.G., M.G.M., G.C., C.M.-E., J.M.G.-P., G.C.V., V.E.B., A.G.-Á., E.Z., E.R.G., M.G.D., J.F.R.-P., A.d.M., M.Á.E.C., P.G.-P., J.G.M.).
1 shared publication
Latest Publications
- 1 August 2025
- Published by Wolters Kluwer Health in Stroke
- Vol. 56 (8) , 2198-2209
Diffusion Tensor Imaging Study After Intraarterial Cell Therapy in Acute Ischemic Stroke: A Substudy of the IBIS Randomized Clinical Trial
BACKGROUND: Bone marrow mononuclear cell (BM-MNC) intraarterial transplantation has emerged as a potential stroke therapy. We aimed to determine whether BM-MNC therapy induces changes in diffusion tensor imaging metrics of major white matter tracts. METHODS: The IBIS trial was an investigator-initiated multicenter, phase IIb, randomized, controlled, assessor-blinded, clinical trial. Seventy-seven patients (aged 18–80 years) with a nonlacunar middle cerebral artery ischemic stroke within 1 to 7 days from stroke onset and a National Institutes of Health Stroke Scale score of 6 to 20 were included. The primary outcome was the modified Rankin Scale score at 6 months. Among these participants, 38 patients (20 BM-MNCs-treated and 18 controls) had diffusion tensor imaging data available at both baseline and 6-month follow-up. Fractional anisotropy, mean diffusivity, axial diffusivity, and radial diffusivity for white matter tracts were obtained. We determined the average changes in diffusion tensor imaging-metric values over the follow-up period and correlated corticospinal tract integrity with clinical outcomes using Spearman´s correlation coefficient. RESULTS: The mean (SD) age was 60.7 (14.01) years; 22 (57.9%) were men, and 31 (81.6%) underwent thrombectomy. The median (interquartile range) National Institutes of Health Stroke Scale score before randomization was 12 (9–15). Baseline diffusion tensor imaging metrics were comparable between groups. Fractional anisotropy values of patients treated with BM-MNC decreased significantly less throughout corticospinal tract ipsilateral to stroke lesion (−0.05 [95% CI, −0.07 to −0.03] versus −0.06 [95% CI, −0.09 to −0.04]; P P r =−0.478], National Institutes of Health Stroke Scale score [ r =−0.594], Barthel index [ r =0.466] at 6 months [all P <0.01]). CONCLUSIONS: Intraarterial autologous BM-MNC transplantation within 7 days after stroke onset seems to modify long-term white matter tract microstructure, suggesting that this cell therapy may mitigate acute stroke damage, through main projection fibers. Greater corticospinal tract preservation was associated with improved clinical outcomes. REGISTRATION: https://www.clinicaltrials.gov ; Unique identifier: NCT02178657.
- 1 August 2025
- Published by Wolters Kluwer Health in Stroke
- Vol. 56 (8) , 2198-2209
Diffusion Tensor Imaging Study After Intraarterial Cell Therapy in Acute Ischemic Stroke: A Substudy of the IBIS Randomized Clinical Trial
BACKGROUND: Bone marrow mononuclear cell (BM-MNC) intraarterial transplantation has emerged as a potential stroke therapy. We aimed to determine whether BM-MNC therapy induces changes in diffusion tensor imaging metrics of major white matter tracts. METHODS: The IBIS trial was an investigator-initiated multicenter, phase IIb, randomized, controlled, assessor-blinded, clinical trial. Seventy-seven patients (aged 18–80 years) with a nonlacunar middle cerebral artery ischemic stroke within 1 to 7 days from stroke onset and a National Institutes of Health Stroke Scale score of 6 to 20 were included. The primary outcome was the modified Rankin Scale score at 6 months. Among these participants, 38 patients (20 BM-MNCs-treated and 18 controls) had diffusion tensor imaging data available at both baseline and 6-month follow-up. Fractional anisotropy, mean diffusivity, axial diffusivity, and radial diffusivity for white matter tracts were obtained. We determined the average changes in diffusion tensor imaging-metric values over the follow-up period and correlated corticospinal tract integrity with clinical outcomes using Spearman´s correlation coefficient. RESULTS: The mean (SD) age was 60.7 (14.01) years; 22 (57.9%) were men, and 31 (81.6%) underwent thrombectomy. The median (interquartile range) National Institutes of Health Stroke Scale score before randomization was 12 (9–15). Baseline diffusion tensor imaging metrics were comparable between groups. Fractional anisotropy values of patients treated with BM-MNC decreased significantly less throughout corticospinal tract ipsilateral to stroke lesion (−0.05 [95% CI, −0.07 to −0.03] versus −0.06 [95% CI, −0.09 to −0.04]; P P r =−0.478], National Institutes of Health Stroke Scale score [ r =−0.594], Barthel index [ r =0.466] at 6 months [all P <0.01]). CONCLUSIONS: Intraarterial autologous BM-MNC transplantation within 7 days after stroke onset seems to modify long-term white matter tract microstructure, suggesting that this cell therapy may mitigate acute stroke damage, through main projection fibers. Greater corticospinal tract preservation was associated with improved clinical outcomes. REGISTRATION: https://www.clinicaltrials.gov ; Unique identifier: NCT02178657.
- 1 April 2024
- Published by Radiological Society of North America (RSNA) in RadioGraphics
- Vol. 44 (4) , e230160
Epicardial Space: Comprehensive Anatomy and Spectrum of Disease
The epicardial space (ES) is the anatomic region located between the myocardium and the pericardium. This space includes the visceral pericardium and the epicardial fat that contains the epicardial coronary arteries, cardiac veins, lymphatic channels, and nerves. The epicardial fat represents the main component of the ES. This fat deposit has been a focus of research in recent years owing to its properties and relationship with coronary gossypiboma plaque and atrial fibrillation. Although this region is sometimes forgotten, a broad spectrum of lesions can be found in the ES and can be divided into neoplastic and nonneoplastic categories. Epicardial neoplastic lesions include lipoma, paraganglioma, metastases, angiosarcoma, and lymphoma. Epicardial nonneoplastic lesions encompass inflammatory infiltrative disorders, such as immunoglobulin G4-related disease and Erdheim-Chester disease, along with hydatidosis, abscesses, coronary abnormalities, pseudoaneurysms, hematoma, lipomatosis, and gossypiboma. Initial imaging of epicardial lesions may be performed with echocardiography, but CT and cardiac MRI are the best imaging modalities to help characterize epicardial lesions. Due to the nonspecific onset of signs and symptoms, the clinical history of a patient can play a crucial role in the diagnosis. A history of malignancy, multisystem diseases, prior trauma, myocardial infarction, or cardiac surgery can help narrow the differential diagnosis. The diagnostic approach to epicardial lesions should be made on the basis of the specific location, characteristic imaging features, and clinical background. ©RSNA, 2024 Test Your Knowledge questions for this article are available in the supplemental material.
- 1 April 2024
- Published by Radiological Society of North America (RSNA) in RadioGraphics
- Vol. 44 (4) , e230160
Epicardial Space: Comprehensive Anatomy and Spectrum of Disease
The epicardial space (ES) is the anatomic region located between the myocardium and the pericardium. This space includes the visceral pericardium and the epicardial fat that contains the epicardial coronary arteries, cardiac veins, lymphatic channels, and nerves. The epicardial fat represents the main component of the ES. This fat deposit has been a focus of research in recent years owing to its properties and relationship with coronary gossypiboma plaque and atrial fibrillation. Although this region is sometimes forgotten, a broad spectrum of lesions can be found in the ES and can be divided into neoplastic and nonneoplastic categories. Epicardial neoplastic lesions include lipoma, paraganglioma, metastases, angiosarcoma, and lymphoma. Epicardial nonneoplastic lesions encompass inflammatory infiltrative disorders, such as immunoglobulin G4-related disease and Erdheim-Chester disease, along with hydatidosis, abscesses, coronary abnormalities, pseudoaneurysms, hematoma, lipomatosis, and gossypiboma. Initial imaging of epicardial lesions may be performed with echocardiography, but CT and cardiac MRI are the best imaging modalities to help characterize epicardial lesions. Due to the nonspecific onset of signs and symptoms, the clinical history of a patient can play a crucial role in the diagnosis. A history of malignancy, multisystem diseases, prior trauma, myocardial infarction, or cardiac surgery can help narrow the differential diagnosis. The diagnostic approach to epicardial lesions should be made on the basis of the specific location, characteristic imaging features, and clinical background. ©RSNA, 2024 Test Your Knowledge questions for this article are available in the supplemental material.
- 1 June 2022
- Published by Wolters Kluwer Health in Circulation: Genomic and Precision Medicine
- Vol. 15 (3) , e003408
Prevalence of Pathogenic Variants in Cardiomyopathy-Associated Genes in Myocarditis
- 1 June 2022
- Published by Wolters Kluwer Health in Circulation: Genomic and Precision Medicine
- Vol. 15 (3) , e003408
Prevalence of Pathogenic Variants in Cardiomyopathy-Associated Genes in Myocarditis
- Open Access
- 1 June 2019
- Published by Elsevier in Annals of the Rheumatic Diseases
- Vol. 78 (Suppl 2) , 1204
SAT0255 EVALUATION OF THE CARDIOVASCULAR INVOLVEMENT OF SYSTEMIC SCLEROSIS USING NON- INVASIVE CARDIAC IMAGING TECHNIQUES
Background: Systemic sclerosis (SSc) is a systemic disease that may affect many organs; among them, cardiac involvement. The prevalence of cardiac involvement in SSc varies depending on the sensitivity of the methods used for its detection. Indirect evidence suggests that subclinical cardiac involvement may eventually occur in the vast majority of patients with SSc. Early detection and monitoring of myocardial involvement are integral to SSc management, as cardiovascular involvement is known to be a poor prognostic indicator when present Objectives: To describe myocardial perfusion abnormalities and potentially associated coronary arteries lesions using non-invasive imaging techniques in a group of patients with SSc and suggestive symptoms of myocardial involvement (symptomatic) in comparison with a control group of patients with SSc without cardiac symptoms Methods: A retrospective observational study was performed including a total of 61 patients diagnosed with SSc, 52 symptomatic, with dyspnea and/or chest pain (57.98 ± 12.3 years, 45 women) and 9 asymptomatic controls (50.2±15.21 years, 8 women). All patients underwent a post-stress (treadmill or pharmacological) myocardic perfusion gated-SPECT, a cold-induced stress SPECT, that were compared to a rest SPECT (to assess ischemia and/or necrosis), as well as a cardiac CT-angiography (to asses significant coronary arteries lesions, considering stenosis of more than 50%) Results: Twenty-one out of the 52 symptomatic patients (50%) showed myocardial perfusion defects in the stress-rest SPECT: 13 (25%) showed ischemia, 13 (25%) fibrosis/necrosis, and 5 (9.6%) ischemia and necrosis. In the cold-induced SPECT, 17 patients (32.7%) had myocardial perfusion abnormalities: 10 (19.2%) showed ischemia, 13 (25%) fibrosis/necrosis and 6 (11.5%) ischemia and necrosis. In the other hand, of the 9 asymptomatic patients only 1 (11%) had ischemia and necrosis in the stress-rest SPECT, being only positive for necrosis in the cold-induced SPECT images. In the cardiac CT-angiography, 7/52 patients (13.4%) showed significant coronary lesions, 4 (57.2%) of them with perfusion defects in the SPECT images, and 3 (42.8%) without significant perfusion alterations Of the 9 asymptomatic patients, 1 (11%) had significant coronary lesions, being the same patient who presented perfusion defects in myocardial SPECT images Conclusion: The gated-SPECT is a sensitive tool for detecting myocardial perfusion alterations, normally with no associated significant coronary lesions, suggesting microvascular abnormalities. In this cohort, myocardial perfusion abnormalities were detected in 50% of symptomatic patients, whereas in only 11% of non-symptomatic patients References [1] Fernández-Codina A, Simeón-Aznar CP2, Pinal-Fernandez I, Rodríguez-Palomares J, Pizzi MN, Hidalgo CE, Guillén-Del Castillo A, Prado-Galbarro FJ, Sarria-Santamera A, Fonollosa-Plà V, Vilardell-Tarrés M. Cardiac involvement in systemic sclerosis: differences between clinical subsets and influence on survival. Rheumatol Int. 2017 Jan;37(1):75-84. doi: 10.1007/s00296-015-3382-2. Epub 2015 Oct 25. [2] Rangarajan V, Matiasz R, Freed BH. Cardiac complications of systemic sclerosis and management: recent progress. Curr Opin Rheumatol. 2017 Nov;29(6):574-584. doi: 10.1097/BOR. Disclosure of Interests: None declared
- 1 June 2019
- Published by Elsevier in Annals of the Rheumatic Diseases
- Vol. 78 (Suppl 2) , 1204
Open AccessSAT0255 EVALUATION OF THE CARDIOVASCULAR INVOLVEMENT OF SYSTEMIC SCLEROSIS USING NON- INVASIVE CARDIAC IMAGING TECHNIQUES
Background: Systemic sclerosis (SSc) is a systemic disease that may affect many organs; among them, cardiac involvement. The prevalence of cardiac involvement in SSc varies depending on the sensitivity of the methods used for its detection. Indirect evidence suggests that subclinical cardiac involvement may eventually occur in the vast majority of patients with SSc. Early detection and monitoring of myocardial involvement are integral to SSc management, as cardiovascular involvement is known to be a poor prognostic indicator when present Objectives: To describe myocardial perfusion abnormalities and potentially associated coronary arteries lesions using non-invasive imaging techniques in a group of patients with SSc and suggestive symptoms of myocardial involvement (symptomatic) in comparison with a control group of patients with SSc without cardiac symptoms Methods: A retrospective observational study was performed including a total of 61 patients diagnosed with SSc, 52 symptomatic, with dyspnea and/or chest pain (57.98 ± 12.3 years, 45 women) and 9 asymptomatic controls (50.2±15.21 years, 8 women). All patients underwent a post-stress (treadmill or pharmacological) myocardic perfusion gated-SPECT, a cold-induced stress SPECT, that were compared to a rest SPECT (to assess ischemia and/or necrosis), as well as a cardiac CT-angiography (to asses significant coronary arteries lesions, considering stenosis of more than 50%) Results: Twenty-one out of the 52 symptomatic patients (50%) showed myocardial perfusion defects in the stress-rest SPECT: 13 (25%) showed ischemia, 13 (25%) fibrosis/necrosis, and 5 (9.6%) ischemia and necrosis. In the cold-induced SPECT, 17 patients (32.7%) had myocardial perfusion abnormalities: 10 (19.2%) showed ischemia, 13 (25%) fibrosis/necrosis and 6 (11.5%) ischemia and necrosis. In the other hand, of the 9 asymptomatic patients only 1 (11%) had ischemia and necrosis in the stress-rest SPECT, being only positive for necrosis in the cold-induced SPECT images. In the cardiac CT-angiography, 7/52 patients (13.4%) showed significant coronary lesions, 4 (57.2%) of them with perfusion defects in the SPECT images, and 3 (42.8%) without significant perfusion alterations Of the 9 asymptomatic patients, 1 (11%) had significant coronary lesions, being the same patient who presented perfusion defects in myocardial SPECT images Conclusion: The gated-SPECT is a sensitive tool for detecting myocardial perfusion alterations, normally with no associated significant coronary lesions, suggesting microvascular abnormalities. In this cohort, myocardial perfusion abnormalities were detected in 50% of symptomatic patients, whereas in only 11% of non-symptomatic patients References [1] Fernández-Codina A, Simeón-Aznar CP2, Pinal-Fernandez I, Rodríguez-Palomares J, Pizzi MN, Hidalgo CE, Guillén-Del Castillo A, Prado-Galbarro FJ, Sarria-Santamera A, Fonollosa-Plà V, Vilardell-Tarrés M. Cardiac involvement in systemic sclerosis: differences between clinical subsets and influence on survival. Rheumatol Int. 2017 Jan;37(1):75-84. doi: 10.1007/s00296-015-3382-2. Epub 2015 Oct 25. [2] Rangarajan V, Matiasz R, Freed BH. Cardiac complications of systemic sclerosis and management: recent progress. Curr Opin Rheumatol. 2017 Nov;29(6):574-584. doi: 10.1097/BOR. Disclosure of Interests: None declared